Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
Clinical trial NCT00343551 · COMPLETED
Trial details
- NCT number
- NCT00343551
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-01-01
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.